Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia - PubMed (original) (raw)
Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia
S G Rane et al. Nat Genet. 1999 May.
Abstract
To ascertain the role of cyclin-dependent kinase 4 (Cdk4) in vivo, we have targeted the mouse Cdk4 locus by homologous recombination to generate two strains of mice, one that lacks Cdk4 expression and one that expresses a Cdk4 molecule with an activating mutation. Embryonic fibroblasts proliferate normally in the absence of Cdk4 but have a delayed S phase on re-entry into the cell cycle. Moreover, mice devoid of Cdk4 are viable, but small in size and infertile. These mice also develop insulin-deficient diabetes due to a reduction in beta-islet pancreatic cells. In contrast, mice expressing a mutant Cdk4 that cannot bind the cell-cycle inhibitor P16INK4a display pancreatic hyperplasia due to abnormal proliferation of beta-islet cells. These results establish Cdk4 as an essential regulator of specific cell types.
Similar articles
- Characterization of the abnormal pancreatic development, reduced growth and infertility in Cdk4 mutant mice.
Mettus RV, Rane SG. Mettus RV, et al. Oncogene. 2003 Nov 20;22(52):8413-21. doi: 10.1038/sj.onc.1206888. Oncogene. 2003. PMID: 14627982 - Genetic rescue of Cdk4 null mice restores pancreatic beta-cell proliferation but not homeostatic cell number.
Martín J, Hunt SL, Dubus P, Sotillo R, Néhmé-Pélluard F, Magnuson MA, Parlow AF, Malumbres M, Ortega S, Barbacid M. Martín J, et al. Oncogene. 2003 Aug 14;22(34):5261-9. doi: 10.1038/sj.onc.1206506. Oncogene. 2003. PMID: 12917627 - In vivo proliferation of differentiated pancreatic islet beta cells in transgenic mice expressing mutated cyclin-dependent kinase 4.
Hino S, Yamaoka T, Yamashita Y, Yamada T, Hata J, Itakura M. Hino S, et al. Diabetologia. 2004 Oct;47(10):1819-30. doi: 10.1007/s00125-004-1522-4. Epub 2004 Oct 6. Diabetologia. 2004. PMID: 15480536 - Cell cycle control of pancreatic beta cell proliferation.
Rane SG, Reddy EP. Rane SG, et al. Front Biosci. 2000 Jan 1;5:D1-19. doi: 10.2741/rane. Front Biosci. 2000. PMID: 10702380 Review.
Cited by
- DDX18 Facilitates the Tumorigenesis of Lung Adenocarcinoma by Promoting Cell Cycle Progression through the Upregulation of CDK4.
Feng B, Wang X, Qiu D, Sun H, Deng J, Tan Y, Ji K, Xu S, Zhang S, Tang C. Feng B, et al. Int J Mol Sci. 2024 May 1;25(9):4953. doi: 10.3390/ijms25094953. Int J Mol Sci. 2024. PMID: 38732173 Free PMC article. - Real-World Data Analysis of CDK4/6 Inhibitor Therapy-A Patient-Centric Single Center Study.
Ge I, Berner K, Mathis M, Hensgen C, Mayer S, Erbes T, Juhasz-Böss I, Asberger J. Ge I, et al. Cancers (Basel). 2024 May 1;16(9):1760. doi: 10.3390/cancers16091760. Cancers (Basel). 2024. PMID: 38730711 Free PMC article. - Male reproductive phenotypes of genetically altered laboratory mice (Mus musculus): a review based on pertinent literature from the last three decades.
Buranaamnuay K. Buranaamnuay K. Front Vet Sci. 2024 Mar 4;11:1272757. doi: 10.3389/fvets.2024.1272757. eCollection 2024. Front Vet Sci. 2024. PMID: 38500604 Free PMC article. Review. - Transactivation of Met signaling by oncogenic Gnaq drives the evolution of melanoma in Hgf-Cdk4 mice.
Mengoni M, Braun AD, Seedarala S, Bonifatius S, Kostenis E, Schanze D, Zenker M, Tüting T, Gaffal E. Mengoni M, et al. Cancer Gene Ther. 2024 Jun;31(6):884-893. doi: 10.1038/s41417-024-00744-0. Epub 2024 Feb 15. Cancer Gene Ther. 2024. PMID: 38360887 Free PMC article. - The CDK4/6 inhibitor revolution - a game-changing era for breast cancer treatment.
Morrison L, Loibl S, Turner NC. Morrison L, et al. Nat Rev Clin Oncol. 2024 Feb;21(2):89-105. doi: 10.1038/s41571-023-00840-4. Epub 2023 Dec 11. Nat Rev Clin Oncol. 2024. PMID: 38082107 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases